A new study on rheumatoid arthritis has found that while individuals look and feel healthy in the years before their symptoms ...

A new way to potentially control when drugs are active or inactive in the body is introduced in a study reported Sept. 24 in Nature. The research showed that, instead of controlling how tightly ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S ...

Skoltech researchers and their colleagues from the Pasteur Institute and the University of Lorraine, France, have uncovered ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and inflammation and immunology (I&I), will present a ...

Seeing the global biopharmaceutical company Creative Biolabs grow its portfolio of antibody engineering has marked a ...

Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer.

Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of solid ...

Researchers mapped immune cells from centenarians, their offspring, and younger controls across three cohorts using multi-omics single-cell profiling. They found that centenarians retain leaner helper ...

A depleter of pathogenic T cells, rosnilimab’s novel MOA generated a differentiated efficacy, tolerability and safety profile ...

People are exposed to millions of fungal spores every day, even potentially harmful ones like those from Aspergillus fumigatus.

People are exposed to millions of fungal spores every day, even potentially harmful ones like those from Aspergillus fumigatus. For most individuals, this constant exposure is harmless, as the immune ...